Skip to content
TWENTYFOURSEVENBIOPHARMA
TWENTYFOURSEVENBIOPHARMA
HOME
LIFE SCIENCES
VIDEOS
PODCASTS
PHOTO LIBRARY
ADVERTISE
ABOUT US
SUBSCRIBE
LGM Pharma Expands U.S. CDMO Capacity and Navigates Reshoring, Supply-Chain Risks
24/7 Biopharma had the opportunity to sit down for a long-form interview about the state of the CDMO industry with Hamilton Lenox, Chief Commercial Officer, and Matt Grazioli, Senior Marketing Manager, of LGM Pharma. The discussion touched on LGM’s recent facility expansions, shifting market demands in the CDMO segment, and how the company is responding to the uncertain state of the global economy, among various other topics.
LATEST VIDEO
24/7 BIOPHARMA uses cookies to ensure that we give you the best experience on our website. If you continue in using the site we assume that you consent to receive all cookies on our website.
Read Privacy Policy and Use of Cookies
Ok